event - ventures

About
Team
funds
Portfolio
Documents
news
Contact
login

About
Team
funds
Portfolio
Documents
news
Contact
login

Sorry, No post found

The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years.

Useful Links

About Us
Blog
Documents Centre
Contact Us
Team

News

o2h Human Health EIS Fund leads an investment into Kuano, using quantum and AI to accelerate the development of new medicine.
o2h ventures backed Small Pharma receives approval for world’s first DMT for depression clinical trial
o2h Ventures invests into the UCL spin out company SomaServe.

Connect with us

Privacy Policy
Blog
Contact us

o2h ventures Limited is regulated and authorised by the Financial Conduct Authority (FRN 812245). Capital at risk, only suitable for high net worth and sophisticated investors